Gossamer Bio Inc. (NASDAQ: GOSS) reported Q4 EPS of ($0.15), $0.02 better than the analyst estimate of ($0.17). Revenue for the quarter came in at $9.34 million versus the consensus estimate of $7.02 million.

For earnings history and earnings-related data on Gossamer Bio Inc. (GOSS) click here.